- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Carcinoma of Urinary Bladder, Superficial in Belgium
Total 526 results
-
Association Pour La Recherche des Thérapeutiques...Roche Pharma AGCompletedRecurrent Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the BladderFrance, Belgium
-
Acrotech Biopharma Inc.CompletedCarcinoma, Transitional Cell | Bladder Cancer | Bladder NeoplasmSpain, France, Belgium, United States, Argentina, Croatia
-
University Hospital, GhentKom Op Tegen KankerRecruitingMuscle-Invasive Bladder CarcinomaBelgium
-
GlaxoSmithKlineCompletedNeoplasms, Urinary BladderBelgium
-
Universiteit AntwerpenUnknownOveractive Bladder, Non Obstructive Urinary RetentionBelgium
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor OveractivityBelgium, Denmark, Norway, Poland, Serbia
-
European Organisation for Research and Treatment...CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerSpain, France, Belgium, Israel, Switzerland, Netherlands, Italy
-
University Hospital, GhentCompleted
-
University Hospital, GhentAstellas Pharma Inc; MedtronicCompleted
-
University Hospital, GhentTerminatedOveractive Bladder SyndromeBelgium
-
University Hospital, GhentCompletedBowen's Disease | Superficial Basal Cell CarcinomaBelgium
-
University Hospital, GhentCompletedPrimary Non-operated Squamous Cell Carcinoma of Oral Cavity | Primary Non-operated Squamous Cell Carcinoma of Oropharynx | Primary Non-operated Squamous Cell Carcinoma of Hypopharynx | Primary Non-operated Squamous Cell Carcinoma of LarynxBelgium
-
University Hospital, GhentCompletedPrimary Non-operated Squamous Cell Carcinoma of Oral Cavity | Primary Non-operated Squamous Cell Carcinoma of Oropharynx | Primary Non-operated Squamous Cell Carcinoma of Hypopharynx | Primary Non-operated Squamous Cell Carcinoma of LarynxBelgium
-
Universiteit AntwerpenLeiden University Medical CenterUnknownOveractive Bladder | Non Obstructive Urinary RetentionBelgium
-
Universiteit AntwerpenUnknown
-
Galderma R&DCompletedSuperficial Basal Cell CarcinomaFinland, Austria, Belgium, France, Italy, Sweden, United Kingdom
-
Universiteit AntwerpenLeiden University Medical CenterUnknownOveractive Bladder | Non Obstructive Urinary RetentionBelgium
-
University Hospital, GhentCompletedSurgery | Bladder Cancer | Urologic CancerBelgium
-
University Hospital, GhentTakedaCompleted
-
European Organisation for Research and Treatment...CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerNetherlands, Spain, United Kingdom, Poland, Belgium, Denmark, Hungary, Germany, Israel, Italy, Austria
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedUpper Tract Urothelial Carcinomas | Urothelial Bladder CancerUnited States, France, Canada, Spain, Italy, Belgium, Germany, Netherlands, United Kingdom, Bulgaria, Greece
-
University Hospital, GhentMedtronicCompletedUrinary Retention | Fecal Incontinence | Overactive Bladder Syndrome | Dysfunctional Voiding | Fowler SyndromeBelgium
-
KU LeuvenAgentschap voor Innovatie door Wetenschap en TechnologieCompletedBladder CancerBelgium
-
Amphora Medical, Inc.Terminated
-
University Hospital, GhentActive, not recruiting
-
Amber Therapeutics LtdActive, not recruiting
-
Axonics Modulation Technologies, Inc.CompletedOveractive BladderNetherlands, France, Belgium, United Kingdom
-
Universiteit AntwerpenRecruitingOveractive Bladder | Voiding Disorders | Pelvic Organ Prolapse | Stress Urinary Incontinence | Urge IncontinenceBelgium
-
Jessa HospitalCompletedBladder Cancer | Antibiotic-associated Diarrhea | Antibiotic Resistant Infection | Antibiotic Resistant Strain | Antibiotic Toxicity | Prostate Hyperplasia | UrosepsisBelgium
-
VitadxFONDATION FORCE POUR L'INNOVATION ET LA RECHERCHE EN SANTERecruitingNon-muscle Invasive Bladder Cancer (NMIBC)France, Belgium, Spain
-
PfizerCompletedNeurogenic Detrusor OveractivityBelgium
-
ADC Therapeutics S.A.TerminatedBreast Cancer | Non Small Cell Lung Cancer | Bladder Cancer | GastroEsophageal CancerUnited States, Belgium
-
Astellas Pharma Europe B.V.Veeda Clinical ResearchCompletedLower Urinary Tract Predominant Storage SymptomsBelgium
-
University Hospital, GhentAlgemeen Ziekenhuis Maria Middelares; AZ Sint-Lucas Gent; AZ Jan Palfijn GentNot yet recruitingOveractive Bladder | Sacral Neuromodulation | Diversity | Onabotulinum Toxin A | Discrete Choice ExperimentBelgium
-
BlueWind MedicalRecruitingTreatment of Patients Suffering From Overactive Bladder (OAB)United States, Belgium, Netherlands, United Kingdom
-
Universitaire Ziekenhuizen KU LeuvenUniversity of Sydney; University of CagliariActive, not recruitingEndometriosis | Surgery | Gynecologic Disease | Endometriosis, Rectum | Endometriosis of Vagina | Endometriosis Rectovaginal Septum | Endometriosis of Colon | Endometriosis of BladderBelgium, Italy, Australia
-
European Organisation for Research and Treatment...National Cancer Institute (NCI); Medical Research Council; NCIC Clinical Trials... and other collaboratorsCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerFrance, Spain, Canada, United States, Denmark, Poland, Belgium, Germany, Netherlands, Italy, United Kingdom, Austria, Australia, Hungary, Slovakia, Israel
-
Bristol-Myers SquibbCompletedTransitional Cell Carcinoma | Bladder Cancer | MetastasisUnited States, Korea, Republic of, United Kingdom, Spain, Australia, France, Thailand, Denmark, Poland, Belgium, Italy, Philippines, Canada, Russian Federation, Greece, Indonesia
-
Rainier TherapeuticsTerminatedUrinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological DiseasesUnited States, Spain, Belgium, France, Germany, Italy, Korea, Republic of, Turkey, Hungary, Netherlands, Serbia, Poland, Russian Federation, Sweden, Moldova, Republic of, Denmark, Ukraine
-
National Multiple Sclerosis CenterTerminatedInterstitial Cystitis | Painful Bladder SyndromeBelgium
-
Astellas Pharma IncCompletedOveractive Bladder | Neurogenic Detrusor OveractivityBelgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom
-
UNICANCERHoffmann-La RocheActive, not recruitingBladder CancerSpain, France, Belgium
-
AllerganCompletedOveractive Bladder | Urinary IncontinencePoland, Germany, United States, Canada, United Kingdom, Belgium
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveSweden, United Kingdom, Belgium, Denmark
-
Jules Bordet InstituteMerck KGaA, Darmstadt, GermanyActive, not recruitingNon-metastatic Muscle Invasive Bladder CancerFrance, Belgium
-
PfizerCompletedNeurogenic Detrusor OveractivityBelgium
-
Jules Bordet InstituteInnate PharmaWithdrawnAdenocarcinoma of the Gastroesophageal Junction | Squamous Cell Carcinoma of the Esophagus | Adenocarcinoma of the EsophagusBelgium
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Belgium, Russian Federation, Czech Republic, Germany, United States
-
European Organisation for Research and Treatment...TerminatedBladder CancerNetherlands, Belgium, Italy, Turkey, Slovakia
-
University of ZurichRecruitingNeurogenic Bladder DysfunctionBelgium, Brazil, Italy, Switzerland